SAF-Holland (SFQ) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
15 Jan, 2026Executive summary
Q3 2024 sales declined 20.4% year-over-year, mainly due to weaker OE demand, but profitability was supported by resilient aftermarket business, strict cost control, and contributions from recent acquisitions including Assali Stefen.
Adjusted EBIT margin held at 9.8% in Q3, reflecting cost discipline and a favorable business mix.
Opened a new tech center in India to strengthen global R&D and regulatory compliance.
Issued a €100 million promissory note, using proceeds to repay €68 million in term loans, improving maturity profile and investor base.
Operating free cash flow was €42.4 million in Q3, with leverage at 1.9x, below the 2024 target.
Financial highlights
Q3 2024 group sales were €439.9 million, down 20.4% year-over-year; organic sales declined 21.5%.
Adjusted EBIT for Q3 was €43.3 million (margin 9.8%); adjusted EPS was €0.42.
For the first nine months, group sales reached €1,452.5 million with a 10.1% adjusted EBIT margin and €1.80 adjusted EPS.
Operating free cash flow was €42.4 million in Q3 and €86.7 million for the nine months.
Net working capital ratio increased to 16.4%, mainly due to acquisitions and higher aftermarket inventory needs.
Outlook and guidance
Full-year 2024 sales forecast specified at around €1.95 billion, with an adjusted EBIT margin of about 10%.
CapEx guidance remains up to 3% of sales.
Market environment expected to remain challenging in 2024, with recovery anticipated in 2025.
Latest events from SAF-Holland
- Profitability and cash flow remained strong despite lower sales, with robust aftermarket support.SFQ
Q4 202520 Mar 2026 - Profitability remained resilient in FY 2025 despite lower sales and ongoing market headwinds.SFQ
Q4 2025 TU18 Feb 2026 - Margins and cash flow improved in 2024 despite lower sales, with margin guidance raised.SFQ
H1 20242 Feb 2026 - Record margin and strong cash flow in 2024 despite sales decline; stable 2025 outlook.SFQ
H2 202426 Dec 2025 - Aims for €3B+ sales and 10–12% EBIT margin by 2030, fueled by innovation and M&A.SFQ
CMD 202529 Nov 2025 - Sales and margins fell on weak OE demand and tariffs, but aftermarket and EMEA remained resilient.SFQ
Q2 202523 Nov 2025 - Sales fell 11.1% but margins and cash flow improved; 2025 outlook maintained.SFQ
Q1 202520 Nov 2025 - Sales and profit fell, but margins, cash flow, and liquidity remain robust; share buyback launched.SFQ
Q3 202513 Nov 2025 - Record 10.1% adjusted EBIT margin achieved despite 11% sales drop, led by aftermarket growth.SFQ
Q4 2024 TU5 Jun 2025